Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.
Gondi V, Paulus R, Bruner DW, Meyers CA, Gore EM, Wolfson A, Werner-Wasik M, Sun AY, Choy H, Movsas B. Gondi V, et al. Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):656-64. doi: 10.1016/j.ijrobp.2013.02.033. Epub 2013 Apr 15. Int J Radiat Oncol Biol Phys. 2013. PMID: 23597420 Free PMC article. Clinical Trial.
Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.
Werner-Wasik M, Scott C, Cox JD, Sause WT, Byhardt RW, Asbell S, Russell A, Komaki R, Lee JS. Werner-Wasik M, et al. Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1475-82. doi: 10.1016/s0360-3016(00)00801-4. Int J Radiat Oncol Biol Phys. 2000. PMID: 11121651
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R. Movsas B, et al. J Clin Oncol. 2005 Apr 1;23(10):2145-54. doi: 10.1200/JCO.2005.07.167. J Clin Oncol. 2005. PMID: 15800308 Clinical Trial.
Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame.
Poltinnikov IM, Fallon K, Xiao Y, Reiff JE, Curran WJ Jr, Werner-Wasik M. Poltinnikov IM, et al. Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):652-8. doi: 10.1016/j.ijrobp.2004.10.030. Int J Radiat Oncol Biol Phys. 2005. PMID: 15936541
Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.
Werner-Wasik M, Swann RS, Bradley J, Graham M, Emami B, Purdy J, Sause W. Werner-Wasik M, et al. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):385-90. doi: 10.1016/j.ijrobp.2007.06.034. Epub 2007 Sep 14. Int J Radiat Oncol Biol Phys. 2008. PMID: 17869017 Clinical Trial.
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
Sarna L, Swann S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Byhardt R, Wasserman T, Movsas B. Sarna L, et al. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1378-84. doi: 10.1016/j.ijrobp.2008.03.003. Epub 2008 May 22. Int J Radiat Oncol Biol Phys. 2008. PMID: 18501528
197 results